Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Sales | 691,300 | 799,100 | 693,800 | 770,300 | 726,900 |
| Cost of Goods | 260,300 | 304,700 | 270,400 | 301,800 | 281,300 |
| Gross Profit | 431,000 | 494,400 | 423,400 | 468,500 | 445,600 |
| Operating Expenses | 380,900 | 403,400 | 365,200 | 383,500 | 375,600 |
| Operating Income | 50,400 | 91,700 | 58,600 | 85,800 | 70,300 |
| Interest Expense | 30,000 | 32,500 | 29,300 | 30,400 | 34,300 |
| Other Income | 17,900 | 18,200 | 15,100 | 800 | -35,400 |
| Pre-tax Income | 38,300 | 77,400 | 44,400 | 56,200 | 600 |
| Income Tax | 15,300 | 31,100 | 18,000 | 22,400 | 1,900 |
| Net Income Continuous | 23,000 | 46,300 | 26,400 | 33,800 | -1,300 |
| Minority Interests | -100 | 0 | -300 | N/A | -100 |
| Net Income | $23,100 | $46,300 | $26,700 | $33,800 | $-1,200 |
| EPS Basic Total Ops | 0.15 | 0.30 | 0.17 | 0.22 | -0.01 |
| EPS Basic Continuous Ops | 0.15 | 0.30 | 0.17 | 0.22 | -0.01 |
| EPS Diluted Total Ops | 0.15 | 0.30 | 0.17 | 0.22 | -0.01 |
| EPS Diluted Continuous Ops | 0.15 | 0.30 | 0.17 | 0.22 | -0.01 |
| EBITDA(a) | $105,800 | $145,800 | $111,700 | $138,000 | $122,900 |